Company record
New Life Pharma LLC
1 FDA warning letter since 2023 and 4 recalls in the last 12 months.
Get an email the day FDA posts anything new about New Life Pharma LLC.
Warning letters
-
DrugsNew Life Pharma LLC
New Life Pharma made unapproved semaglutide and tirzepatide sterile vials without sterility controls and refused FDA access to some areas.
High risk
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Mar 11 | Class II | New Life Pharma LLC Drug |
Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06 Lack of Assurance of Sterility |
| Mar 11 | Class II | New Life Pharma LLC Drug |
Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04. Lack of Assurance of Sterility |
| Mar 11 | Class II | New Life Pharma LLC Drug |
Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03. Lack of Assurance of Sterility |
| Mar 11 | Class II | New Life Pharma LLC Drug |
Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07. Lack of Assurance of Sterility |